XORTX to focus on late stage allopurinol intolerant gout program; discussion with FDA planned for first half 2025 regarding ...

It has been awarded a fast-track review by the FDA, which Sobi said “underscores the urgent need for new treatment options for patients with chronic refractory gout.” If approved, it will ...

In addition to adherence challenges, discontinuation of prescription treatment due to adverse effects is also a challenge in the medical management of gout.

This wealth of new information provides a treasure trove of potential targets for future treatments and could revolutionize our understanding of gout. Professor Tony Merriman, the study’s senior ...

If you have gout, a doctor can help you develop a treatment plan to manage your flares ... and legumes. Shifting to a new diet may be more effective than trying to add a handful of gout-friendly ...

Gout tophi totally disappeared and renal function remained stable. The patient continues to receive rasburicase treatment. P Richette is a Rheumatologist and T Bardin is a Professor of ...

For patients with gout who cannot get relief ... Now, phase 3 results with a new drug from Sobi and Selecta suggests there could be another treatment option in the offing. Armed with a pair ...

Treatment of gout was inadequate in most cases. CONCLUSIONS Hyperuricaemia and gout remain common among Maori. Of concern is that the prevalence of gout appears to be on the increase, not only in ...

METHODS Prospective, parallel, open study of 86 consecutive male patients with primary chronic gout. Forty nine patients (26 normal excretors and 23 under excretors) were given allopurinol 300 mg/day ...

From atopic dermatitis to contact dermatitis, discover expert-backed treatments and lifestyle changes that can help manage ...

Objective To test the hypothesis that gouty arthritis (gout) is a risk factor for incidence of heart failure and for echocardiographic measures signifying subclinical heart failure. Design Post-hoc, ...